The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

FTC wants more in­for­ma­tion on No­vo-Catal­ent deal in an­titrust re­view

Last year
Deals

Bi­par­ti­san draft bill would pay hos­pi­tals more to com­bat drug short­ages

Last year
Pharma

Emer­gent to shut fa­cil­i­ties and lay off work­ers as part of new CEO’s roadmap

Last year

Avid Bio field­ing client in­quiries due to Chi­na bill; Ox­ford Bio wants to dou­ble its rev­enues

Last year

Up­dat­ed: Lil­ly boosts sales guid­ance by $2B, but GLP-1 sup­ply con­straints still a fo­cus

Last year
Pharma

WuXi wants to re­gain client con­fi­dence amid claims of IP trans­fer to Chi­nese au­thor­i­ties 

Last year
China

Mer­ck KGaA to ex­pand Ger­man head­quar­ters with €300M+ re­search cen­ter 

Last year
R&D

Ther­mo Fish­er ex­pects last­ing ben­e­fits to bill tar­get­ing Chi­nese ser­vice providers

Last year
China

Roche un­ruf­fled by Chi­na bill as it looks to grow roots in the re­gion

Last year
China

Drug and biotech com­pa­nies join lob­by­ing push on Chi­na bill as scruti­ny of WuXi con­tin­ues

Last year
China
Pharma

Sam­sung Bio’s bet on Plant 4 con­tin­ues to pay off with first-quar­ter earn­ings growth

Last year

Ver­tex li­cens­es TreeFrog’s tech to up­scale cell ther­a­py man­u­fac­tur­ing for di­a­betes can­di­dates

Last year
Deals
Pharma

Shi­madzu Cor­po­ra­tion es­tab­lish­es three R&D cen­ters in the US in an­tic­i­pa­tion of busi­ness ex­pan­sion for phar­ma­ceu­ti­cal com­pa­nies

Last year
Nikkei Biotechnology

Lil­ly nabs in­jectable med­i­cines fa­cil­i­ty from Nexus Phar­ma

Last year
Pharma

FDA hands CRL to Abeon­a's rare skin dis­ease cell ther­a­py

Last year
FDA+

Bris­tol My­ers, Cel­lares sign glob­al CAR-T deal as bio­phar­ma com­pa­nies look to di­ver­si­fy man­u­fac­tur­ing part­ners 

Last year
Deals
Cell/Gene Tx

Vedan­ta lays off CMC staffers; Kin­cell buys Imu­gene fa­cil­i­ty for $6M

Last year

J&J, Bris­tol My­ers race to am­pli­fy CAR-T man­u­fac­tur­ing to meet la­bel ex­pan­sion in mul­ti­ple myelo­ma

Last year
Cell/Gene Tx

Fu­ji­film is all in on AD­Cs, to sell ‘trust’ to boost man­u­fac­tur­ing rev­enues

Last year

Fu­ji­film may cut 240 work­ers and re­build ear­ly-stage bi­o­log­ics, CGT unit

Last year
People

Re­ci­pharm’s new CEO on ‘fast and fu­ri­ous’ changes, with eyes on GLP-1, bi­o­log­ics man­u­fac­tur­ing

Last year

Fu­ji­film in­vests $1.2B to ex­pand North Car­oli­na bio­man­u­fac­tur­ing fa­cil­i­ty

Last year

As­cend takes Bea­con’s man­u­fac­tur­ing as­sets; 89bio’s $135M build in Chi­na

Last year

Mod­er­na halts African fa­cil­i­ty build as Covid-19 vac­cine de­mand plum­mets

Last year
First page Previous page 12131415161718 Next page Last page
A service from the Financial Times